iCAD is a global medical technology leader providing innovative cancer detection and therapy solutions. We work passionately to provide precise, powerful healthcare solutions expertly engineered to optimize operational efficiency, clinician confidence and patient outcomes.
Read our response to COVID-19 and learn how our portfolio of solutions supporting cancer detection and therapy continue to offer significant benefits to clinicians, patients and the overall healthcare system.
November 24, 2020
iCAD Reports Over 1,000 Licenses Sold as Part of ProFound AI Sales
» View All News »
© 2020, iCAD Inc. All rights reserved. iCAD, the iCAD logo, PowerLook, ProFound AI, ProFound, Xoft, the Xoft logo, Axxent, Electronic Brachytherapy System and eBx are trademarks of iCAD, Inc. Reproduction of any of the material contained herein in any format or media without the express written permission of iCAD, Inc. is prohibited.